Previous Page  814 / 827 Next Page
Information
Show Menu
Previous Page 814 / 827 Next Page
Page Background

844

cytometry was determined the number of CD3, CD19, CD4, CD8,

CD16/56 cells; the level of expression of activation markers on the

monocytes and lymphocytes (HLA- DR/CD14, CD71/CD14, CD25/

CD4, CD95/CD3); adhesion receptor (CD11b). All premature babies

with leukopenia in the background found an increase in the relative

number of lymphocytes and decreased ability to absorb opsonized

bacteria by granulocytes. Defined a reduction in the percentage

of HLA-DR+/CD14+-cells, increasing the number of CD3+CD95+-

population in group of children with a GA 25-28 weeks. Decrease at

the level of NK-cells in group infants less than 32 weeks of GA was

observed. It was determined a reduced percentage of CD3+CD11b+

cells in the 29-32; 33-36 weeks of GA. At the 33-36 weeks of the GA

found a reduction in the number CD3+CD95+ lymphocytes and

increasedexpressionof theCD25+CD4+ lymphocytes.

Overall, the findings suggest about the features of the immune

system, specific to a particular GA preterm infants. A number of

the investigated parameters give the opportunity to talk about the

partial achievement of the immunological response preparedness

for a potential antigen that dictates the need for further research

aimed at understanding the functional activity of immune cells.

The importance of serum visfatin levels in Behcet’s disease

patients

Ozbalkan,Z.

1

,Enecik,M.E.

1

,Keskin,G.

2

,Karaaslan,Y.

1

1

AnkaraNumuneEducationandResearchHospital,Rheumatology

Department,Ankara,Turkey,

2

AnkaraUniversitySchoolof Medicine,

ImmunologyDepartmet,Ankara,Turkey

Objectives:

Addipose tissue is an active endocrine organ and

releases adipositokines. Visfatine is one of them. Visfatin is related to

TNF-α and IL-6, IL-1 beta, co-stimulators like CD40, CD54 ,CD 80 and

endothelial ICAM-1 and ICAM-2. We aimed to search the relation

among levels of serumvisfatin in BD activity.

Materials andmethods:

60BD patients (30 in active state and 30 in

remission) diagnosed according to criteria of WGIBD and 20 healthy

subjects as controls were involeved in to the study. Serum visfatin

levels were compared in between three groups.

Results:

Visfatin levels were significantly higher in both group of

patients compared to the healthy control group (both p< 0,001).

Serum visfatin levels in active state patients were higher than those

in inactive state (p < 0.001). The same way in all cases statistically

significant correlation between visfatin and CRP (p < 0.001) and

visfatin and ESR (p< 0.01). According to the symptoms of the

patients in the active state, patients with genital aphtous ulcers had

higher serum visfatin levels than the active patients without genital

aphthous ulcers (p<0,001).

Conclusion:

Serum visfatin levels in BD patients with active and

inactive states are higher than the healthy control group. That could

be concluded as visfatin as a proinflammatory cytokines have a

role in chronic inflammatory reactions and sustains the cellular

expressionof the inflammatory cytokines inBD.

Kinetic analysis of type 2 innate lymphoid cells in tissues from

IL-25- and IL-33-induced murine models of asthma

Li, Y.

1

, Lv, Z.

2

,Wang, J.

3

, Chi, Y.

3

, Huang, P.

2

, Corrigan, C.J.

4

, Huang, K.

1

,

Wang,W.

2

, Ying, S.

2

1

Beijing Chao-Yang Hospital, Capital Medical University & Beijing

Institute of Respiratory Medicine, Department of Respiratory and

Critical Care Medicine, Beijing, China,

2

Capital Medical University,

Department of Immunology, School of Basic Medical Sciences,

Beijing,China,

3

CapitalMedicalUniversity,DepartmentofLaboratory

Animal Sciences, Beijing, China,

4

King’s College London, MRC &

Asthma UK Centre in Allergic Mechanisms of Asthma, Division of

Asthma, Allergy & Lung Biology, London, UnitedKingdom

Background:

Type-2innatelymphoidcells(ILC2)playimportantrole

in the pathogenesis of asthma through producing large amounts of

Th2-type cytokines. The mechanisms of ILC2 chemotaxis into lungs,

however, are still unclear.

Methods:

To answer these, BALB/c mice were intranasally changed

with murine IL-25 or IL-33, while OVA and saline challenged mice

were used as positive and negative controls. Bone marrow, spleen,

thymus, mesenteric lymph nodes, mediastinal lymph nodes, lung

tissue and bronchoalveolar lavage fluid (BALF) were collected from

themice at experimental acute, subacute, chronic and convalescent

phases. Flowcytometry, invitrochemotaxis assayandsmall animal in

vivo imaging were used tomeasure the distribution and abundance

and chemotaxis of ILC2

invitro

and

invivo

.

Results:

Both IL-25 and IL-33 alone induced accumulation of ILC2

into mediastinal lymph nodes, lung tissue and BALF, but with

different kinetics. The peak of IL-25 induced ILC2 accumulation into

lung tissue and BALF was earlier than that of the IL-33- induced

mice. In quantity, the numbers of ILC2 in BALF, lung tissue and

mediastinal lymph nodes were significantly higher in IL- 33-induced

mice compared with IL-25-induced mice.

In vitro

IL-33, but not IL-

25 directly induced ILC2 chemotaxis. Small animal

in vivo

imaging

further confirmed that single intranasally inhalation of IL-33 was

sufficient to induce accumulation of injected ILC2 through tail vein

into the lungs.

Conclusion:

The data suggest that airways epithelium-derived IL-25

or IL-33 can induce accumulation of ILC2 to the lungs and that IL-33

has direct effect on ILC2 chemotaxis.

Immune responses to oral polio vaccine (OPV) in patients with

X-linked agammaglobulinemia (XLA)

Wu, Y.

1

,Mao, H.W.

2

, Chan, S.M.

1

, Lam, K.T.

1

, Tu,W.

1

, Lau, Y.L.

1

1

UniversityofHongKong,PaediatricsandAdolescentMedicine,Hong

Kong,HongKong,

2

HKU-ShenZhenHospital,ShenZhen, China

Background

: XLA is characterized by impaired antibody response

resulting fromBruton´s tyrosine kinase (BTK) mutation. Unlike other

primary immunodeficiency with no predisposition to extraordinary

risk of viral infection, XLA renders a unique susceptibility to

enteroviruses infection including poliovirus. OPV can induce

paralytic poliomyelitis in XLA patients. Of great public concern is

that the attenuated OPV can persist and revert to a virulent form in

these patients, which renders a high risk of reintroducing virulent

poliovirus into general population. It is known that BTK is involved

in toll-like receptor 3 (TLR3) signaling, and TLR3-mediated type I IFN

responses play critical roles in host protection against poliovirus.

However, whether XLA patients have impaired type I IFN responses

toOPV are not clear.

Hypothesis

: BTK mutations in XLA impair TLR3-mediated type I IFN

response, leading to the unique susceptibility to poliovirus in XLA

patients.